Age and Gender Heterogeneity in Adverse Drug Reactions Associated with Hemp Use: Evidence from the FDA Pharmacovigilance Data in the Last Two Decades

Key Points

• The aim is to explore how age and gender impact adverse drug reactions related to hemp-derived products.
• Analyzed FDA pharmacovigilance data from the last two decades.
• Examined adverse drug reactions associated with hemp use.
• Compared incidence rates by age and gender.
• Identified serious neurological and psychiatric events linked to hemp use.
• Observed significant variation in adverse reactions based on age.
• Noted gender differences in the severity and type of adverse drug reactions.